Sanofi Ordered to Pay €150.7 Million in Anti-Competition Ruling
Sanofi has been ordered to pay €150.7 million ($177.1 million) in damages to France’s national health insurance fund (CNAM) after a Paris appeals court found the drugmaker engaged in anti-competitive practices to protect sales of its anti-clotting drug Plavix, Reuters first reported.
